发明名称 |
APTZAYME CAPABLE OF SELECTIVE SILENCING OF TARGET miRNA BY RELEASING AN ANTISENSE SEQUENCE IN HEPATITIS C VIRUS-INFECTED CELLS AND USE THEREOF |
摘要 |
The present invention relates to an aptazyme comprising an aptamer for hepatitis C virus (HCV) RNA-encoding component; a hammerhead ribozyme comprising an antisense sequence to microRNA at the site released by self-cleavage; and a communication module sequence that connects the aptamer and hammerhead ribozyme and triggers a self-cleavage activity of the hammerhead ribozyme upon binding of the aptamer with the HCV RNA-encoding component. The present aptazyme inhibits microRNA activity specifically in HCV proliferating cells and thus a composition of the present invention comprising the aptazyme can be effectively used for treatment of HCV-related diseases.
|
申请公布号 |
US2013245094(A1) |
申请公布日期 |
2013.09.19 |
申请号 |
US201113823845 |
申请日期 |
2011.09.16 |
申请人 |
INDUSTRY-ACADEMIC COOPERATION FOUNDATION DANKOOK UNIVERSITY |
发明人 |
LEE SEONG-WOOK;LEE CHANG-HO |
分类号 |
C12N15/113;C12N15/10 |
主分类号 |
C12N15/113 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|